ALIF-BNasdaq StockholmHealth CareIFRS · SEK

AddLife

AddLife is a European company specializing in the distribution and development of advanced medical technology products and laboratory equipment. The company focuses on two main business areas: Labtech and Medtech, providing innovative solutions to healthcare and research institutions. AddLife has strengthened its market position through strategic acquisitions and organic growth, with a significant presence across Europe. The company is committed to improving margins and profitability through efficiency improvements and a focus on high-margin, advanced products.

Ask about the company
Revenue10.4bn SEK
+1.5 %y/y
Operating profit (EBIT)993m SEK
+37.7 %y/y
EBIT margin9.5%
+2.5 ppy/y
Net income562m SEK
+121.3 %y/y

Fiscal year 2025 · change from previous year

Development 2020–2025

0.02.55.07.510.012.5bn SEK2020: 5.3 bn SEK2020: EBIT 0.67 bn SEK20202021: 8.0 bn SEK2021: EBIT 1.00 bn SEK20212022: 9.1 bn SEK2022: EBIT 0.81 bn SEK20222023: 9.7 bn SEK2023: EBIT 0.59 bn SEK20232024: 10.3 bn SEK2024: EBIT 0.72 bn SEK20242025: 10.4 bn SEK2025: EBIT 0.99 bn SEK202510.40.99
RevenueOperating profit (EBIT)
Ask Clarifo about AddLife

Business

Share of revenue
Labtech40 %

Includes laboratory equipment and testing solutions

Medtech60 %

Comprises advanced medical devices and homecare products

Customers

AddLife serves a diverse range of customers primarily within the healthcare and research sectors. Key customer segments include hospitals, research institutions, and pharmaceutical companies, which rely on AddLife's advanced products for critical applications. The company's strong service offerings and niche market positioning make it a preferred partner for institutions looking to improve healthcare delivery and research outcomes. AddLife's focus on high-margin products attracts customers seeking innovative and reliable solutions.

Hospitals

Buy advanced medical devices for patient care

Research Institutions

Use lab equipment for scientific research

Pharmaceutical Companies

Require testing solutions for drug development

Homecare Providers

Utilize specialized products for patient support

Strategy

AddLife's strategic priorities include improving margins, driving organic growth, and expanding through acquisitions. The company focuses on shifting its product portfolio towards high-margin, advanced products to enhance profitability. Efficiency improvements and cost control are key components of its strategy to strengthen financial performance. AddLife aims to leverage its strong market position and customer relationships to support future growth and innovation.

Margin ImprovementMedium term

Enhance profitability through high-margin products

Organic GrowthMedium term

Expand market presence and product offerings

Strategic AcquisitionsLong term

Strengthen market position and product portfolio

Geography

AddLife has a strong presence across Europe, with significant operations in the Nordics, Ireland, Spain, and Italy. The company has expanded its market reach through strategic acquisitions in Southern and Western Europe, enhancing its industry-leading position. Manufacturing and distribution are primarily centered in Europe, allowing AddLife to efficiently serve its key markets. The company's geographic focus supports its strategy of leveraging regional expertise to drive growth and innovation.

Risks

AddLife faces several business and financial risks, including economic fluctuations and market trends that can impact demand for its products. The company's reliance on public sector contracts and policy decisions poses a risk, as changes can affect revenue stability. Competition in the medical technology sector is intense, requiring continuous innovation and differentiation. Additionally, geopolitical uncertainties, such as those in Ukraine and the Middle East, may indirectly affect operations and supply chains.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Economic Fluctuations1Competition2Public Sector Contracts3Geopolitical Uncertainties4
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Economic FluctuationsImpact: HighLikelihood: Medium

    Affect demand for medical technology products

  2. CompetitionImpact: HighLikelihood: Medium

    Requires continuous innovation and differentiation

  3. Public Sector ContractsImpact: MediumLikelihood: Medium

    Changes in policy can impact revenue stability

  4. Geopolitical UncertaintiesImpact: MediumLikelihood: Medium

    May affect operations and supply chains

Ask Clarifo about AddLife

Accounting

Judgemental items
Revenue Recognition

Affects timing and comparability of financial results

Impact: high

Currency Fluctuations

Impact reported revenue and profitability

Impact: medium

Goodwill Accounting

Affects balance sheet valuations

Impact: medium

Similar listed companies

Publicly listed companies with a comparable business focus.

Addtech

ADDT-B · Industrials

Alleima

ALLEI · Basic Materials

MetLife, Inc

MET · Life Insurance

Aditxt, Inc.

ADTX · Pharmaceutical Preparations

Davion Healthcare PLC

DAVI · Surgical & Medical Instruments & Apparatus

Medtronic plc

MDT · Electromedical & Electrotherapeutic Apparatus

Last updated: 24/09/2026